Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEE POTEF POTEI	9.25e-06	11	78	3	GO:0098973
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	POTEE POTEF POTEI ERBIN EPB42 ADD3	1.19e-05	130	78	6	GO:0005200
GeneOntologyMolecularFunction	structural constituent of postsynapse	POTEE POTEF POTEI	2.62e-04	32	78	3	GO:0099186
GeneOntologyMolecularFunction	structural constituent of synapse	POTEE POTEF POTEI	5.90e-04	42	78	3	GO:0098918
GeneOntologyMolecularFunction	superoxide-generating NADPH oxidase activator activity	NCF1C NCF1B	6.64e-04	10	78	2	GO:0016176
GeneOntologyMolecularFunction	dynein light chain binding	DYNC1I1 DYNC1I2	9.69e-04	12	78	2	GO:0045503
GeneOntologyMolecularFunction	superoxide-generating NAD(P)H oxidase activity	NCF1C NCF1B	9.69e-04	12	78	2	GO:0016175
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	POTEE POTEF POTEI	2.21e-04	32	77	3	GO:0035267
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	POTEE POTEF POTEI	2.21e-04	32	77	3	GO:0043189
GeneOntologyCellularComponent	actin cytoskeleton	POTEE MYH4 ACACA PDLIM1 POTEF LRRC7 POTEI ARHGAP21 OPHN1	2.62e-04	576	77	9	GO:0015629
GeneOntologyCellularComponent	histone acetyltransferase complex	POTEE JADE3 POTEF POTEI	4.04e-04	94	77	4	GO:0000123
GeneOntologyCellularComponent	protein acetyltransferase complex	POTEE JADE3 POTEF POTEI	5.92e-04	104	77	4	GO:0031248
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	POTEE POTEF POTEI	6.10e-04	45	77	3	GO:1902562
GeneOntologyCellularComponent	acetyltransferase complex	POTEE JADE3 POTEF POTEI	7.06e-04	109	77	4	GO:1902493
Domain	DYNC1I1/DYNC1I2	DYNC1I1 DYNC1I2	1.51e-05	2	73	2	IPR025956
Domain	Dynein_IC2	DYNC1I1 DYNC1I2	1.51e-05	2	73	2	PF11540
Domain	Actin_CS	POTEE POTEF POTEI	3.09e-05	16	73	3	IPR004001
Domain	ACTINS_2	POTEE POTEF POTEI	3.75e-05	17	73	3	PS00432
Domain	Actin/actin-like_CS	POTEE POTEF POTEI	4.48e-05	18	73	3	IPR020902
Domain	ACTINS_ACT_LIKE	POTEE POTEF POTEI	5.31e-05	19	73	3	PS01132
Domain	Actin	POTEE POTEF POTEI	2.38e-04	31	73	3	IPR004000
Domain	Actin	POTEE POTEF POTEI	2.38e-04	31	73	3	PF00022
Domain	ACTIN	POTEE POTEF POTEI	2.38e-04	31	73	3	SM00268
Domain	I-BAR_dom	BAIAP2L2 OPHN1	1.14e-03	13	73	2	IPR013606
Domain	PDZ	PDLIM1 LRRC7 ERBIN ARHGAP21	2.26e-03	141	73	4	PF00595
Domain	PDZ	PDLIM1 LRRC7 ERBIN ARHGAP21	2.70e-03	148	73	4	SM00228
Domain	-	PDLIM1 LRRC7 ERBIN ARHGAP21	2.83e-03	150	73	4	2.30.42.10
Domain	PDZ	PDLIM1 LRRC7 ERBIN ARHGAP21	2.90e-03	151	73	4	PS50106
Domain	PDZ	PDLIM1 LRRC7 ERBIN ARHGAP21	2.97e-03	152	73	4	IPR001478
Domain	EPHD	JADE3 RAI1	3.31e-03	22	73	2	PS51805
Domain	SH3_9	ITSN2 ARHGEF38 BAIAP2L2	3.53e-03	78	73	3	PF14604
Domain	SH3_2	ITSN2 ARHGEF38 BAIAP2L2	4.65e-03	86	73	3	IPR011511
Domain	SH3_2	ITSN2 ARHGEF38 BAIAP2L2	4.65e-03	86	73	3	PF07653
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	ITSN2 BUB1 NCF1C NCF1B ERBIN ARHGAP21 BAIAP2L2 DYNC1I1 DYNC1I2 MRTFA OPHN1 ADD3	1.79e-05	649	61	12	MM15690
Pathway	REACTOME_RHOF_GTPASE_CYCLE	POTEE ARHGAP21 BAIAP2L2 ADD3	3.14e-05	42	61	4	M41821
Pathway	REACTOME_RAC2_GTPASE_CYCLE	NCF1C NCF1B ERBIN ARHGAP21 OPHN1	3.61e-05	87	61	5	MM15600
Pathway	REACTOME_RAC3_GTPASE_CYCLE	NCF1C NCF1B ERBIN ARHGAP21 OPHN1	4.98e-05	93	61	5	MM15609
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	POTEE ITSN2 BUB1 ERBIN ARHGAP21 BAIAP2L2 DYNC1I1 DYNC1I2 MRTFA OPHN1 ADD3	2.30e-04	720	61	11	M41838
Pathway	KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE	BUB1 DYNC1I1 DYNC1I2	2.88e-04	30	61	3	M47889
Pubmed	Angiopoietin-1-induced angiogenesis is modulated by endothelial NADPH oxidase.	ANGPT1 NCF1C NCF1B	4.33e-08	4	78	3	16679392
Pubmed	Type III interferon is a critical regulator of innate antifungal immunity.	NCF1C NCF1B STAT1	1.08e-07	5	78	3	28986419
Pubmed	Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo.	IDO1 NCF1C NCF1B	1.08e-07	5	78	3	24281189
Pubmed	Myricitrin Modulates NADPH Oxidase-Dependent ROS Production to Inhibit Endotoxin-Mediated Inflammation by Blocking the JAK/STAT1 and NOX2/p47phox Pathways.	NCF1C NCF1B STAT1	1.08e-07	5	78	3	28751937
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ACACA TTC28 PDLIM1 USP15 ERBIN JMJD1C EMSY PCM1 STAT1 ADD3	4.26e-07	549	78	10	38280479
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ACACA TTC28 PDLIM1 JADE3 ITSN2 USP15 ARHGAP21 EMSY DYNC1I1 PCM1 DYNC1I2 USP47	4.32e-07	853	78	12	28718761
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	RC3H2 ACACA TTC28 ERBIN ARHGAP21 PCM1 ADD3	4.71e-07	209	78	7	36779422
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	ZSCAN12 SLFN13 XK EIF3I EXOC7 JMJD1C ARHGAP21 GALNT4	1.90e-06	371	78	8	15747579
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	PDLIM1 MKI67 ZFHX3 PSPC1 JMJD1C EMSY AFF4	3.54e-06	283	78	7	30585729
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	C4orf17 POTEE MYH4 POTEF ITSN2 MARF1 POTEI PSPC1 ERBIN TOP3B ARHGAP21 DYNC1I1 DYNC1I2 RAI1	3.55e-06	1442	78	14	35575683
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ACACA TTC28 BUB1 ZFHX3 JMJD1C ARHGAP21 PCM1 MRTFA	4.58e-06	418	78	8	34709266
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	POTEE POTEF POTEI	4.84e-06	15	78	3	16824795
Pubmed	Stimulation of inducible nitric oxide synthase expression by beta interferon increases necrotic death of macrophages upon Listeria monocytogenes infection.	NCF1C NCF1B STAT1	4.84e-06	15	78	3	18268032
Pubmed	A primate-specific POTE-actin fusion protein plays a role in apoptosis.	POTEE POTEF	4.97e-06	2	78	2	19669888
Pubmed	Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance.	IDO1 PTGS2	4.97e-06	2	78	2	28765120
Pubmed	The interplay between indoleamine 2,3-dioxygenase 1 (IDO1) and cyclooxygenase (COX)-2 in chronic inflammation and cancer.	IDO1 PTGS2	4.97e-06	2	78	2	21517752
Pubmed	Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.	IDO1 STAT1	4.97e-06	2	78	2	22828446
Pubmed	Functional pseudogenes inhibit the superoxide production.	NCF1C NCF1B	4.97e-06	2	78	2	26086043
Pubmed	Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma.	MKI67 PTGS2	4.97e-06	2	78	2	26423666
Pubmed	Cloning and characterization of two cytoplasmic dynein intermediate chain genes in mouse and human.	DYNC1I1 DYNC1I2	4.97e-06	2	78	2	10049579
Pubmed	Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan.	IDO1 PTGS2	4.97e-06	2	78	2	31759380
Pubmed	Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells.	IDO1 PTGS2	4.97e-06	2	78	2	23973990
Pubmed	Peptidoglycan induces cyclooxygenase-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway.	SMPD2 PTGS2	4.97e-06	2	78	2	19531467
Pubmed	Inhibition of the Na+/K+-ATPase by cardiac glycosides suppresses expression of the IDO1 immune checkpoint in cancer cells by reducing STAT1 activation.	IDO1 STAT1	4.97e-06	2	78	2	35150740
Pubmed	Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative splicing and tissue distribution of transcripts.	DYNC1I1 DYNC1I2	4.97e-06	2	78	2	20657784
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ACACA PDLIM1 MKI67 EIF3I ERBIN ARHGAP21 EMSY PCM1 STAT1 AFF4 ADD3	7.45e-06	934	78	11	33916271
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ACACA JADE3 MKI67 ELF1 ERBIN EMSY PCM1 DYNC1I2 MRTFA USP47	9.05e-06	774	78	10	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	PUS3 ACACA TTC28 SLFN13 MKI67 ZFHX3 ERBIN ARHGAP21 PCM1 ADD3	9.35e-06	777	78	10	35844135
Pubmed	Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome.	NCF1C NCF1B	1.49e-05	3	78	2	27044504
Pubmed	NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.	NCF1C NCF1B	1.49e-05	3	78	2	18787174
Pubmed	Deficient production of reactive oxygen species leads to severe chronic DSS-induced colitis in Ncf1/p47phox-mutant mice.	NCF1C NCF1B	1.49e-05	3	78	2	24873968
Pubmed	p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice.	NCF1C NCF1B	1.49e-05	3	78	2	22184329
Pubmed	Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis.	NCF1C NCF1B	1.49e-05	3	78	2	33545139
Pubmed	Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis.	NCF1C NCF1B	1.49e-05	3	78	2	20142487
Pubmed	p47(phox) contributes to albuminuria and kidney fibrosis in mice.	NCF1C NCF1B	1.49e-05	3	78	2	25565313
Pubmed	Knockout of neutrophil cytosolic factor 1 ameliorates neuroinflammation and motor deficit after traumatic brain injury.	NCF1C NCF1B	1.49e-05	3	78	2	39357591
Pubmed	Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells.	NCF1C NCF1B	1.49e-05	3	78	2	11435342
Pubmed	Neutrophil Cytosolic Factor 1 in Dendritic Cells Promotes Autoreactive CD8+ T Cell Activation via Cross-Presentation in Type 1 Diabetes.	NCF1C NCF1B	1.49e-05	3	78	2	31118934
Pubmed	Virulence comparisons of Aspergillus nidulans mutants are confounded by the inflammatory response of p47phox-/- mice.	NCF1C NCF1B	1.49e-05	3	78	2	16041040
Pubmed	Expression of COX-2, p16, and Ki67 in the range from normal breast tissue to breast cancer.	MKI67 PTGS2	1.49e-05	3	78	2	33147051
Pubmed	Intermittent hypoxia has organ-specific effects on oxidative stress.	NCF1C NCF1B	1.49e-05	3	78	2	18703411
Pubmed	Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion.	NCF1C NCF1B	1.49e-05	3	78	2	17307863
Pubmed	Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.	NCF1C NCF1B	1.49e-05	3	78	2	27829407
Pubmed	The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.	NCF1C NCF1B	1.49e-05	3	78	2	22376231
Pubmed	Leishmania amazonensis amastigotes trigger neutrophil activation but resist neutrophil microbicidal mechanisms.	NCF1C NCF1B	1.49e-05	3	78	2	23918780
Pubmed	NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells.	NCF1C NCF1B	1.49e-05	3	78	2	28274989
Pubmed	Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.	NCF1C NCF1B	1.49e-05	3	78	2	12364355
Pubmed	NOX2-Deficient Neutrophils Facilitate Joint Inflammation Through Higher Pro-Inflammatory and Weakened Immune Checkpoint Activities.	NCF1C NCF1B	1.49e-05	3	78	2	34557202
Pubmed	Reactive Oxygen Species Regulate Both Priming and Established Arthritis, but with Different Mechanisms.	NCF1C NCF1B	1.49e-05	3	78	2	28467721
Pubmed	P47(phox)-deficient NADPH oxidase defect in neutrophils of diabetic mouse strains, C57BL/6J-m db/db and db/+.	NCF1C NCF1B	1.49e-05	3	78	2	10670582
Pubmed	Direct Comparison of a Natural Loss-Of-Function Single Nucleotide Polymorphism with a Targeted Deletion in the Ncf1 Gene Reveals Different Phenotypes.	NCF1C NCF1B	1.49e-05	3	78	2	26528554
Pubmed	The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis.	NCF1C NCF1B	1.49e-05	3	78	2	19052348
Pubmed	Effect of early particulate air pollution exposure on obesity in mice: role of p47phox.	NCF1C NCF1B	1.49e-05	3	78	2	20864666
Pubmed	Reactive oxygen species delay control of lymphocytic choriomeningitis virus.	NCF1C NCF1B	1.49e-05	3	78	2	23328631
Pubmed	p47phox-Dependent Oxidant Signalling through ASK1, MKK3/6 and MAPKs in Angiotensin II-Induced Cardiac Hypertrophy and Apoptosis.	NCF1C NCF1B	1.49e-05	3	78	2	34572995
Pubmed	Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice.	NCF1C NCF1B	1.49e-05	3	78	2	17114280
Pubmed	B-cell epitope spreading and inflammation in a mouse model of arthritis is associated with a deficiency in reactive oxygen species production.	NCF1C NCF1B	1.49e-05	3	78	2	25989352
Pubmed	Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase.	NCF1C NCF1B	1.49e-05	3	78	2	17404617
Pubmed	Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.	NCF1C NCF1B	1.49e-05	3	78	2	17332431
Pubmed	Lpp of Escherichia coli K1 inhibits host ROS production to counteract neutrophil-mediated elimination.	NCF1C NCF1B	1.49e-05	3	78	2	36592568
Pubmed	Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression.	NCF1C NCF1B	1.49e-05	3	78	2	30504842
Pubmed	Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism.	NCF1C NCF1B	1.49e-05	3	78	2	33705493
Pubmed	Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis.	NCF1C NCF1B	1.49e-05	3	78	2	23965970
Pubmed	Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice.	NCF1C NCF1B	1.49e-05	3	78	2	15513930
Pubmed	Phosphoinositide 3-kinase regulates the phosphorylation of NADPH oxidase component p47(phox) by controlling cPKC/PKCdelta but not Akt.	NCF1C NCF1B	1.49e-05	3	78	2	15033459
Pubmed	Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles.	NCF1C NCF1B	1.49e-05	3	78	2	20828610
Pubmed	p47phox Phox homology domain regulates plasma membrane but not phagosome neutrophil NADPH oxidase activation.	NCF1C NCF1B	1.49e-05	3	78	2	20817944
Pubmed	NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions.	NCF1C NCF1B	1.49e-05	3	78	2	36853827
Pubmed	Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation.	NCF1C NCF1B	1.49e-05	3	78	2	23024271
Pubmed	Co-Expression of p16, Ki67 and COX-2 Is Associated with Basal Phenotype in High-Grade Ductal Carcinoma In Situ of the Breast.	MKI67 PTGS2	1.49e-05	3	78	2	25711229
Pubmed	Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells.	NCF1C NCF1B	1.49e-05	3	78	2	21253614
Pubmed	Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.	NCF1C NCF1B	1.49e-05	3	78	2	15310853
Pubmed	Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.	NCF1C NCF1B	1.49e-05	3	78	2	31393787
Pubmed	Vascular effects following homozygous disruption of p47(phox) : An essential component of NADPH oxidase.	NCF1C NCF1B	1.49e-05	3	78	2	10725280
Pubmed	Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice.	NCF1C NCF1B	1.49e-05	3	78	2	34970267
Pubmed	Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?	MKI67 PTGS2	1.49e-05	3	78	2	23301386
Pubmed	Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility.	NCF1C NCF1B	1.49e-05	3	78	2	25689796
Pubmed	Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.	NCF1C NCF1B	1.49e-05	3	78	2	14993144
Pubmed	Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation.	NCF1C NCF1B	1.49e-05	3	78	2	22050439
Pubmed	The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression.	NCF1C NCF1B	1.49e-05	3	78	2	12031896
Pubmed	NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion.	NCF1C NCF1B	1.49e-05	3	78	2	11249873
Pubmed	Ncf1 (p47phox) polymorphism determines oxidative burst and the severity of arthritis in rats and mice.	NCF1C NCF1B	1.49e-05	3	78	2	15936744
Pubmed	NADPH oxidase p47phox siRNA attenuates adventitial fibroblasts proliferation and migration in apoE(-/-) mouse.	NCF1C NCF1B	1.49e-05	3	78	2	25628043
Pubmed	Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit.	NCF1C NCF1B	1.49e-05	3	78	2	12560337
Pubmed	Inhibition of endothelial Nox2 activation by LMH001 protects mice from angiotensin II-induced vascular oxidative stress, hypertension and aortic aneurysm.	NCF1C NCF1B	1.49e-05	3	78	2	35276443
Pubmed	Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(-/-) mice.	NCF1C NCF1B	1.49e-05	3	78	2	19381132
Pubmed	Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection.	NCF1C NCF1B	1.49e-05	3	78	2	12176908
Pubmed	A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease.	NCF1C NCF1B	1.49e-05	3	78	2	9329953
Pubmed	Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice.	NCF1C NCF1B	1.49e-05	3	78	2	10799876
Pubmed	Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha.	NCF1C NCF1B	1.49e-05	3	78	2	11834706
Pubmed	A model of chronic enthesitis and new bone formation characterized by multimodal imaging.	NCF1C NCF1B	1.49e-05	3	78	2	30045841
Pubmed	Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease.	NCF1C NCF1B	1.49e-05	3	78	2	19635825
Pubmed	The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells.	NCF1C NCF1B	1.49e-05	3	78	2	35788118
Pubmed	Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation.	NCF1C NCF1B	1.49e-05	3	78	2	17310103
Pubmed	Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia.	NCF1C NCF1B	1.49e-05	3	78	2	18036262
Pubmed	Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice.	NCF1C NCF1B	1.49e-05	3	78	2	10678931
Pubmed	Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species.	NCF1C NCF1B	1.49e-05	3	78	2	17167081
Pubmed	Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors.	NCF1C NCF1B	1.49e-05	3	78	2	24358335
Pubmed	Molecular characterization of the mouse p47-phox (Ncf1) gene and comparative analysis of the mouse p47-phox (Ncf1) gene to the human NCF1 gene.	NCF1C NCF1B	1.49e-05	3	78	2	10891396
Pubmed	P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.	NCF1C NCF1B	1.49e-05	3	78	2	25474113
Interaction	HDAC1 interactions	PWWP2A MYH4 ACACA TTC28 BUB1 MKI67 ZFHX3 USP15 JMJD1C ARHGAP21 EMSY PCM1 STAT1 MRTFA RAI1 USP47	2.98e-06	1108	76	16	int:HDAC1
Interaction	GSK3B interactions	RC3H2 ACACA TTC28 PDLIM1 MKI67 ZNF227 ERBIN ARHGAP21 DYNC1I1 PCM1 DYNC1I2 MRTFA RAI1 ADD3	3.89e-06	868	76	14	int:GSK3B
Interaction	FMR1 interactions	POTEE RC3H2 ZSCAN12 MKI67 PSPC1 TOP3B ARHGAP21 EMSY DYNC1I1 PCM1 AFF4	5.10e-06	536	76	11	int:FMR1
Interaction	RCOR1 interactions	ACACA TTC28 BUB1 MKI67 ZFHX3 USP15 JMJD1C ARHGAP21 PCM1 MRTFA	1.60e-05	494	76	10	int:RCOR1
Interaction	SNRNP40 interactions	RC3H2 ACACA PDLIM1 JADE3 ITSN2 MKI67 ELF1 ZFHX3 USP15 TOP3B EMSY	2.56e-05	637	76	11	int:SNRNP40
Interaction	PHF21A interactions	ACACA TTC28 BUB1 ZFHX3 JMJD1C ARHGAP21 PCM1 MRTFA	4.47e-05	343	76	8	int:PHF21A
Interaction	KDM1A interactions	C4orf17 ACACA TTC28 ITSN2 BUB1 ZFHX3 EXOC7 PSPC1 USP15 JMJD1C ARHGAP21 PCM1 MRTFA	4.58e-05	941	76	13	int:KDM1A
Interaction	H1-0 interactions	PWWP2A RC3H2 MKI67 ELF1 USP15 JMJD1C RAI1	5.10e-05	256	76	7	int:H1-0
Interaction	NINL interactions	TTC28 JADE3 ITSN2 ZFHX3 TOP3B ARHGAP21 MRPS22 PCM1 DYNC1I2	5.53e-05	458	76	9	int:NINL
Interaction	ALG13 interactions	RC3H2 IQCA1 MARF1 NXF2 JMJD1C PCM1	6.67e-05	183	76	6	int:ALG13
Interaction	H2AZ1 interactions	PWWP2A RC3H2 ACACA JADE3 JMJD1C EMSY AFF4 RAI1	7.75e-05	371	76	8	int:H2AZ1
Cytoband	2q21.1	POTEE POTEF POTEI	1.36e-04	58	78	3	2q21.1
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEE POTEF POTEI	8.31e-06	13	57	3	685
GeneFamily	Dyneins, cytoplasmic	DYNC1I1 DYNC1I2	7.45e-04	13	57	2	538
GeneFamily	PDZ domain containing	PDLIM1 LRRC7 ERBIN ARHGAP21	1.34e-03	152	57	4	1220
Coexpression	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	ANGPT1 TTC28 IDO1 NEGR1 PTGS2 STAT1 MX2	4.28e-07	156	78	7	M17275
Coexpression	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	ANGPT1 TTC28 IDO1 NEGR1 PTGS2 STAT1 MX2	1.25e-06	183	78	7	M6670
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_B_CELL	PDLIM1 CD22 ELF1 NCF1C ADD3	1.30e-05	101	78	5	M39045
Coexpression	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	PDLIM1 IDO1 NEGR1 PTGS2 STAT1 MX2	1.45e-05	176	78	6	M15588
Coexpression	HU_FETAL_RETINA_BLOOD	BUB1 MKI67 ELF1 XK USP15 EPB42 ADD3	2.13e-05	282	78	7	M39263
Coexpression	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	ANGPT1 IDO1 NEGR1 PTGS2 STAT1 MX2	2.44e-05	193	78	6	M13479
Coexpression	GSE17721_POLYIC_VS_CPG_16H_BMDC_UP	ELF1 XK USP15 STAT1 MX2 ADD3	2.98e-05	200	78	6	M3950
Coexpression	GLINSKY_CANCER_DEATH_UP	BUB1 MKI67	1.30e-04	6	78	2	MM1267
Coexpression	GLINSKY_CANCER_DEATH_UP	BUB1 MKI67	1.82e-04	7	78	2	M13007
Coexpression	NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP	IDO1 CALHM6 STAT1	2.31e-04	40	78	3	M40897
Coexpression	GALIE_TUMOR_ANGIOGENESIS	ANGPT1 PTGS2	2.42e-04	8	78	2	M1294
Coexpression	GALIE_TUMOR_ANGIOGENESIS	ANGPT1 PTGS2	2.42e-04	8	78	2	MM1123
Coexpression	ZHU_CMV_8_HR_UP	IDO1 PTGS2 MX2	2.49e-04	41	78	3	M4710
Coexpression	GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP	NECTIN3 NCF1C PTGS2 STAT1 MX2	2.74e-04	192	78	5	M9509
Coexpression	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN	ZSCAN12 CALHM6 PTGS2 STAT1 MX2	2.74e-04	192	78	5	M4296
Coexpression	GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN	CALHM6 NECTIN3 USP15 PTGS2 STAT1	2.81e-04	193	78	5	M6150
Coexpression	GSE29618_BCELL_VS_MDC_UP	CD22 NCF1C AFF4 OPHN1 ADD3	2.87e-04	194	78	5	M4943
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN	ZSCAN12 IDO1 NCF1C PTGS2 MX2	2.94e-04	195	78	5	M4279
Coexpression	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP	MRM3 MYH4 NECTIN3 EIF3I TOP3B	3.01e-04	196	78	5	M5569
Coexpression	GSE3982_MAST_CELL_VS_NEUTROPHIL_DN	MARF1 NECTIN3 JMJD1C OPHN1 MX2	3.09e-04	197	78	5	M5433
Coexpression	GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP	PATL2 TTC28 CSMD1 STAT1 MX2	3.09e-04	197	78	5	M7545
Coexpression	GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	PUS3 ELF1 PTGS2 MRPS22 EMSY	3.16e-04	198	78	5	M5782
Coexpression	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP	PDLIM1 CD22 MARF1 STAT1 MX2	3.16e-04	198	78	5	M6025
Coexpression	GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP	RC3H2 ANGPT1 TTC28 SCG2 ADD3	3.23e-04	199	78	5	M5978
Coexpression	GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP	SLC7A8 NEGR1 SLFN13 DYNC1I2 MX2	3.23e-04	199	78	5	M7817
Coexpression	GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	RC3H2 PUS3 XK MRPS22 EMSY	3.23e-04	199	78	5	M5799
Coexpression	GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN	MRM3 PDLIM1 SLFN13 CALHM6 RAI1	3.23e-04	199	78	5	M5771
Coexpression	GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN	ITSN2 ELF1 ERBIN ARHGAP21 DYNC1I2	3.31e-04	200	78	5	M7744
Coexpression	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	IDO1 ELF1 USP15 STAT1 MX2	3.31e-04	200	78	5	M8967
Coexpression	GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	PWWP2A ACACA MARF1 EXOC7 PSPC1	3.31e-04	200	78	5	M332
Coexpression	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	SLFN13 ELF1 CALHM6 STAT1 MX2	3.31e-04	200	78	5	M8559
Coexpression	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	SLFN13 ELF1 CALHM6 STAT1 MX2	3.31e-04	200	78	5	M8554
Coexpression	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	IDO1 SLFN13 CALHM6 STAT1 MX2	3.31e-04	200	78	5	M7322
Coexpression	GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	ELF1 STAT1 MRTFA RAI1 ADD3	3.31e-04	200	78	5	M7205
Coexpression	GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	SLC7A8 BUB1 PXT1 NXF2 ZFHX3	3.31e-04	200	78	5	M6990
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	MRM3 ZSCAN12 TTC28 ITSN2 MKI67 MARF1 GOLIM4 ALDH6A1 ERBIN EMSY AFF4 OPHN1	2.60e-05	780	78	12	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ITSN2 USP15 JMJD1C PCM1 STAT1 AFF4 MX2	6.25e-08	200	78	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD22 ITSN2 ELF1 JMJD1C STAT1 AFF4	8.14e-07	182	78	6	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ZFHX3 CSMD1 USP15 NCF1C JMJD1C PTGS2	9.24e-07	186	78	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Mild/Remission-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ELF1 CALHM6 USP15 JMJD1C STAT1 MX2	1.08e-06	191	78	6	382686d62f7b8576c44bb9726a4e10dc26fd348e
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	TTC28 NEGR1 ZFHX3 MRTFA OPHN1 ADD3	1.18e-06	194	78	6	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC7A8 PWWP2A SCG2 ZFHX3 CCL11 OPHN1	1.22e-06	195	78	6	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ELF1 USP15 ERBIN JMJD1C STAT1 MX2	1.29e-06	197	78	6	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ELF1 USP15 ERBIN JMJD1C STAT1 MX2	1.33e-06	198	78	6	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ELF1 USP15 ERBIN JMJD1C STAT1 MX2	1.33e-06	198	78	6	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	368C-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	IDO1 BUB1 MKI67 MARF1 LRRC7	6.68e-06	150	78	5	c3ad5fa41eb636a5d691c0268c0f1c32cd0de658
ToppCell	368C-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	IDO1 BUB1 MKI67 MARF1 LRRC7	6.68e-06	150	78	5	78b8029e71d26f336a46274c8afef3435bf536b9
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GOLIM4 ERBIN JMJD1C ARHGAP21 PCM1	1.45e-05	176	78	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 SCG2 DYNC1I1 DYNC1I2 ADD3	1.62e-05	180	78	5	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 SCG2 DYNC1I1 DYNC1I2 ADD3	1.62e-05	180	78	5	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD22 ITSN2 ELF1 JMJD1C AFF4	1.75e-05	183	78	5	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	IDO1 JMJD1C STAT1 AFF4 MX2	1.75e-05	183	78	5	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD22 ITSN2 ELF1 JMJD1C AFF4	1.75e-05	183	78	5	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITSN2 ELF1 ERBIN JMJD1C PCM1	1.80e-05	184	78	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ANO2 TTC28 PDLIM1 IDO1 CSMD1	1.80e-05	184	78	5	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITSN2 ELF1 ERBIN JMJD1C PCM1	1.84e-05	185	78	5	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NECTIN3 ERBIN JMJD1C AFF4 USP47	1.84e-05	185	78	5	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	JADE3 CCL11 NECTIN3 PTGS2 ADD3	1.84e-05	185	78	5	d5f5866924648a3c14e2596218fd548a31777aa3
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	JADE3 MARF1 GOLIM4 ERBIN ADD3	1.89e-05	186	78	5	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDLIM1 NEGR1 CCL11 NECTIN3 ADD3	1.99e-05	188	78	5	aa516273cdde53c8c0295f06830972388f890c97
ToppCell	Mild/Remission-B_activate-7\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CALHM6 USP15 JMJD1C STAT1 MX2	2.32e-05	194	78	5	01c97543972159a9468272da06e7e611e2c21fae
ToppCell	COVID-19_Convalescent-PLT_4\|COVID-19_Convalescent / Disease Group and Platelet Clusters	ELF1 XK PSPC1 USP15 JMJD1C	2.32e-05	194	78	5	ce1fad4e76a87f0c35e430ed1f2262395df882fd
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	TTC28 NEGR1 ZFHX3 OPHN1 ADD3	2.37e-05	195	78	5	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	NEGR1 ZFHX3 MRTFA OPHN1 ADD3	2.37e-05	195	78	5	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ITSN2 ELF1 ZNF227 USP47 ADD3	2.43e-05	196	78	5	ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLC9A2 SCG2 ARHGEF38 XK EPB42	2.43e-05	196	78	5	50aaca81b593ff71790bb75403b2e4c3ab03a6d2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	POTEF NCF1C JMJD1C PTGS2 MX2	2.49e-05	197	78	5	d2b2eaa6f7294ff56b84a69c8727c7e0f9fd0466
ToppCell	Mild-CD8+_T_activated\|Mild / Disease group and Cell class	PATL2 ELF1 USP15 STAT1 MX2	2.55e-05	198	78	5	ceac1b51bacfd0dd7fe7c6a666f7927055e1f380
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NEGR1 LRRC7 CSMD1 DYNC1I1 DYNC1I2	2.55e-05	198	78	5	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ELF1 USP15 STAT1 AFF4 MX2	2.68e-05	200	78	5	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	RC3H2 JADE3 JMJD1C OPHN1	9.31e-05	135	78	4	b128596653a5e3b64ed7f657bbfeda35438e2e48
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD22 MARF1 CALHM6 ERBIN	9.31e-05	135	78	4	7743a01dc9c4542e910e7c0fe046004692a680bf
ToppCell	facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQCA1 DYTN LRRC7 MX2	1.10e-04	141	78	4	4aa4b3476dc5abefbd348353cfe711cd5fe3d52f
ToppCell	facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQCA1 DYTN LRRC7 MX2	1.10e-04	141	78	4	e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8
ToppCell	facs-Heart-Unknown-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQCA1 DYTN LRRC7 MX2	1.13e-04	142	78	4	759fbbd15b4fb313bd6269b7f087edafebd530ef
ToppCell	Monocytes-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	POTEF CALHM6 EPB42 MX2	1.59e-04	155	78	4	82abfcee23ba08a1eb4208d367393285026e5388
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CD22 MARF1 CALHM6 ERBIN	1.59e-04	155	78	4	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	Severe-B_naive-1\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CD22 MARF1 CALHM6 ERBIN	1.75e-04	159	78	4	2881b054bbeb479221ee3c38bbd9b0815b123579
ToppCell	TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11\|TCGA-Brain / Sample_Type by Project: Shred V9	POTEE POTEF POTEI	1.85e-04	63	78	3	d7dc1356a60cb527fe668328d5375f352239d911
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ANGPT1 PDLIM1 IQCA1 PTGS2	1.88e-04	162	78	4	2d28306c6125b31f11ea6d911a167b93a74907c5
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 HS3ST5 XK ZBBX	2.01e-04	165	78	4	0c714e852f912b5749de4cb0895406673979b2e6
ToppCell	PCW_07-8.5-Epithelial-Epithelial_ciliated\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 HS3ST5 XK ZBBX	2.01e-04	165	78	4	82530f96aaefe28a13bad0474bbad043f127a86c
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGEF38 HS3ST5 ZFHX3 CSMD1	2.16e-04	168	78	4	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells\|GI_small-bowel / Manually curated celltypes from each tissue	PDLIM1 CD22 JADE3 ZBBX	2.16e-04	168	78	4	8e025bb0541746e232b77ac0e31412ae71420c47
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_B\|GI_small-bowel / Manually curated celltypes from each tissue	PDLIM1 CD22 JADE3 ZBBX	2.16e-04	168	78	4	5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC7A8 CSMD1 BAIAP2L2 STAT1	2.26e-04	170	78	4	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	Control-B_naive-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MARF1 CALHM6 ERBIN EMSY	2.31e-04	171	78	4	d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLFN13 GOLIM4 XK BAIAP2L2	2.36e-04	172	78	4	e3a8891694343b6b01e80a200ae338d24797e417
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_10\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IDO1 JADE3 DYNC1I1 GALNT4	2.41e-04	173	78	4	09a13407a41ff2cba82fc417b72bf9a24ce6c42e
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_10\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IDO1 JADE3 DYNC1I1 GALNT4	2.41e-04	173	78	4	bfec038a6783f166240da4861e100643c6ea80a5
ToppCell	wk_20-22-Hematologic-Myeloid-CXCL9+_Mac\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PATL2 CALHM6 STAT1 MX2	2.52e-04	175	78	4	48f5bdbfc1ba40c3fb6411f12a69e61da2138296
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	ANO2 CSMD1 PTGS2 DYNC1I1	2.52e-04	175	78	4	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	POTEE SCG2 POTEI ZBBX	2.52e-04	175	78	4	182e45f5c02214d6b9f317ff5dc43af8b42de978
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC7A8 CSMD1 BAIAP2L2 STAT1	2.52e-04	175	78	4	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SLC9A2 ACACA ARHGEF38 HS3ST5	2.58e-04	176	78	4	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PATL2 SCG2 ARHGEF38 STAT1	2.63e-04	177	78	4	fd4a297e519b3959811a462d63feebff76429031
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-regulatory_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PATL2 SCG2 ARHGEF38 STAT1	2.63e-04	177	78	4	e995230ef207dcd87eab4550617589016ffa9970
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZSCAN12 PDLIM1 CD22 LRRC7	2.63e-04	177	78	4	3535575686c9700ab72700aae6f2070ebbb50044
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITSN2 PCM1 STAT1 MX2	2.69e-04	178	78	4	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGEF38 ARHGAP21 AFF4 RAI1	2.75e-04	179	78	4	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	POTEE PDLIM1 POTEF POTEI	2.81e-04	180	78	4	fb3d549c2a69b2157a486786ddd775ca16699ed0
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	POTEE PDLIM1 POTEF POTEI	2.81e-04	180	78	4	beb4d777e0c5fa0a59672dbc3dbb7732498605ff
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PWWP2A NEGR1 SCG2 DYNC1I1	2.81e-04	180	78	4	f6a2208960d0df1500c974cc44c3c054cd7475a9
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	NEGR1 SCG2 POTEI DYNC1I1	2.93e-04	182	78	4	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ERBIN STAT1 MX2 ADD3	2.93e-04	182	78	4	1aea96ee211f7b9caef7fd385233f51be6021a73
ToppCell	COVID-19_Mild\|World / Disease Group and Platelet Clusters	ELF1 ERBIN JMJD1C STAT1	2.93e-04	182	78	4	90c61e10c7860bfba6ccfe6f37671c8924637f7b
ToppCell	COVID-19_Mild-CD4+_T_activated\|COVID-19_Mild / Disease condition and Cell class	MARF1 ERBIN STAT1 MX2	2.93e-04	182	78	4	877b6e611626628e709568747512f2827ebb2795
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ERBIN STAT1 MX2 ADD3	2.93e-04	182	78	4	b427e43ee523a3ea9eca3207f3d82042f10f022a
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERBIN STAT1 MX2 ADD3	2.93e-04	182	78	4	c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERBIN STAT1 MX2 ADD3	2.93e-04	182	78	4	4cb182ef39be2044a6ad7266f332d4177591e550
ToppCell	COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated\|COVID-19_Mild / Disease group, lineage and cell class	ERBIN STAT1 MX2 ADD3	2.99e-04	183	78	4	7717fce227b4e02ed41baad8ae7dd2e22bd7c13e
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PDLIM1 CD22 STAT1 MX2	2.99e-04	183	78	4	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANGPT1 NEGR1 HS3ST5 LRRC7	2.99e-04	183	78	4	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	COVID-19_Mild-CD8+_T_activated\|COVID-19_Mild / Disease condition and Cell class	PATL2 STAT1 DYNC1I2 MX2	2.99e-04	183	78	4	ac1ca5d613fa9888ccc63cb0bdce95aefd02cdd7
ToppCell	Control-CD8+_T_activated\|Control / Disease group and Cell class	MRM3 STAT1 RAI1 MX2	3.05e-04	184	78	4	b86cc48b744b3206880ec1373fe6068e14bf9680
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ZFHX3 LRRC7 CCL11 CSMD1	3.11e-04	185	78	4	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	COVID-cycling-\|COVID / Condition, Cell_class and T cell subcluster	BUB1 MKI67 XK EPB42	3.11e-04	185	78	4	eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDLIM1 CD22 CALHM6 NCF1C	3.11e-04	185	78	4	38e07b3f846f8a929c22424a526b69bf66e0b220
ToppCell	LPS_only\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IDO1 USP15 PTGS2 STAT1	3.11e-04	185	78	4	a72ccb147ca505880e2da8f6a70b9d570464a691
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 ZFHX3 LRRC7 CCL11	3.11e-04	185	78	4	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	COVID-cycling\|COVID / Condition, Cell_class and T cell subcluster	BUB1 MKI67 XK EPB42	3.11e-04	185	78	4	5112f966735fa48f0606adcfd5c0212ad5d3d77a
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NEGR1 ZFHX3 LRRC7 CCL11	3.18e-04	186	78	4	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	Control-Endothelial_cells-Arterial_endothelial_cells\|Control / group, cell type (main and fine annotations)	ANO2 TTC28 IDO1 CSMD1	3.24e-04	187	78	4	81affaab3fe3e1daea45ada6445e906ddd33950e
ToppCell	droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JADE3 BUB1 MKI67 XK	3.31e-04	188	78	4	1a3f95b4fd7611c634666761ddf21f1e58e56af8
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Airway_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ANGPT1 NEGR1 ZFHX3 CCL11	3.38e-04	189	78	4	4f9608b84d135268a17455661870c46ae8554a24
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IDO1 SCG2 HS3ST5 LRRC7	3.38e-04	189	78	4	3e8e30160a8d6f531ff743cb5918c9e79481f1bd
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDLIM1 CD22 JADE3 CALHM6	3.38e-04	189	78	4	886dceacf96e2b6750c146a381da0bf96a2bb15b
ToppCell	10x5'-blood-Lymphocytic_B\|blood / Manually curated celltypes from each tissue	PDLIM1 CD22 JADE3 CALHM6	3.38e-04	189	78	4	9837dca502c9a7f42efb0bc74f3e88e7461e7dc8
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IDO1 SCG2 HS3ST5 LRRC7	3.38e-04	189	78	4	851f8144aed5c7f80302911cd6b03f14bde7b56d
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SLFN13 BUB1 ARHGEF38 MKI67	3.38e-04	189	78	4	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDLIM1 CD22 JADE3 CALHM6	3.38e-04	189	78	4	5f1f4321939877374a8ee13de93f2d1390af8e2e
ToppCell	390C-Lymphocytic-B_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PDLIM1 CD22 JADE3 CALHM6	3.44e-04	190	78	4	f63c9474f23bb72f0bb1fc531342f0da04ed8b3e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDLIM1 CD22 JADE3 CALHM6	3.44e-04	190	78	4	60bb6aaea9691d07295f61c14d1650f5041a0f9c
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IDO1 SCG2 HS3ST5 LRRC7	3.44e-04	190	78	4	1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDLIM1 CD22 CALHM6 NCF1C	3.44e-04	190	78	4	441770ce7b3c81f36f5b15b8e51794f736462457
ToppCell	390C-Lymphocytic-B_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PDLIM1 CD22 JADE3 CALHM6	3.44e-04	190	78	4	53bf211f0e8a44f5adb89c43b210a1e35120b6a8
Computational	Genes upregulated in subsets of cells of a given type within various tumors	IDO1 CCL11 STAT1 MX2	4.47e-05	50	43	4	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_INTERFERON
Computational	Genes upregulated in subsets of cells of a given type within various tumors	IDO1 CALHM6 STAT1 MX2	4.47e-05	50	43	4	GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON
Computational	Neighborhood of DLG1	MARF1 ERBIN ARHGAP21 DYNC1I2	2.68e-04	79	43	4	GCM_DLG1
Drug	Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	SLC7A8 TTC28 EXOC7 TOP3B PCM1 STAT1 MRTFA ADD3	3.26e-07	193	78	8	4394_DN
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A	ZFHX3 SMPD2 ZNF227 ALDH6A1 PCM1 AFF4 MRTFA	4.96e-06	196	78	7	3272_DN
Disease	Obesity	IDO1 NEGR1 ZFHX3 ALDH6A1 PTGS2 AFF4 RAI1	7.09e-07	205	72	7	C0028754
Disease	Malignant neoplasm of breast	SLC9A2 IDO1 ITSN2 ARHGEF38 MKI67 GOLIM4 LRRC7 PTGS2 MRPS22 EMSY STAT1	5.58e-05	1074	72	11	C0006142
Disease	chronic granulomatous disease (implicated_via_orthology)	NCF1C NCF1B	5.84e-05	5	72	2	DOID:3265 (implicated_via_orthology)
Disease	Neoplasm Recurrence, Local	IDO1 ITSN2 PTGS2	1.20e-04	39	72	3	C0027643
Disease	Inflammation	ANGPT1 IDO1 CCL11 PTGS2	2.68e-04	127	72	4	C0021368
Disease	susceptibility to common cold measurement	ANGPT1 ARHGEF38 MRTFA	3.16e-04	54	72	3	EFO_0008417
Disease	Peripheral Nervous System Diseases	MKI67 XK DYNC1I1	3.16e-04	54	72	3	C4721453
Disease	Barrett's esophagus (is_marker_for)	MKI67 PTGS2	3.18e-04	11	72	2	DOID:9206 (is_marker_for)
Disease	rheumatoid arthritis (implicated_via_orthology)	NCF1C NCF1B	3.81e-04	12	72	2	DOID:7148 (implicated_via_orthology)
Disease	prostatitis (biomarker_via_orthology)	CCL11 PTGS2	3.81e-04	12	72	2	DOID:14654 (biomarker_via_orthology)
Disease	asthma (biomarker_via_orthology)	CCL11 PTGS2 STAT1	4.11e-04	59	72	3	DOID:2841 (biomarker_via_orthology)
Disease	Brain Ischemia	CCL11 PTGS2 ADD3	4.31e-04	60	72	3	C0007786
Disease	Cerebral Ischemia	CCL11 PTGS2 ADD3	4.31e-04	60	72	3	C0917798
Disease	pleurisy (implicated_via_orthology)	CCL11 PTGS2	4.50e-04	13	72	2	DOID:10247 (implicated_via_orthology)
Disease	Endometrioma	SLC7A8 IDO1 CCL11 PTGS2	6.58e-04	161	72	4	C0269102
Disease	Endometriosis	SLC7A8 IDO1 CCL11 PTGS2	6.58e-04	161	72	4	C0014175
Disease	interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement	SCG2 JMJD1C	6.89e-04	16	72	2	EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293
Disease	spinal stenosis	CALHM6 DYNC1I1	7.80e-04	17	72	2	EFO_0007490
Disease	anti-Mullerian hormone measurement	MYH4 TTC28	1.08e-03	20	72	2	EFO_0004769
Disease	age-related hearing impairment	TTC28 HS3ST5 CSMD1 BAIAP2L2 DYNC1I1	1.19e-03	324	72	5	EFO_0005782
Disease	in situ carcinoma (is_marker_for)	MKI67 PTGS2	1.20e-03	21	72	2	DOID:8719 (is_marker_for)
Disease	fat intake measurement	NEGR1 ITSN2	1.31e-03	22	72	2	EFO_0010809
Disease	physical activity	ANO2 LRRC7 CSMD1	1.32e-03	88	72	3	EFO_0003940
Disease	Liver carcinoma	ACACA BUB1 MKI67 CSMD1 PTGS2 STAT1	1.50e-03	507	72	6	C2239176
Disease	nephrotic syndrome (implicated_via_orthology)	ITSN2 PTGS2	1.57e-03	24	72	2	DOID:1184 (implicated_via_orthology)
Disease	S-warfarin to R-warfarin ratio measurement	PDLIM1 GOLIM4 DYNC1I1	1.64e-03	95	72	3	EFO_0803331
Disease	Mammary Carcinoma, Human	IDO1 ITSN2 MKI67 PTGS2 MRPS22 EMSY	1.79e-03	525	72	6	C4704874
Disease	Mammary Neoplasms, Human	IDO1 ITSN2 MKI67 PTGS2 MRPS22 EMSY	1.79e-03	525	72	6	C1257931
Disease	Mammary Neoplasms	IDO1 ITSN2 MKI67 PTGS2 MRPS22 EMSY	1.82e-03	527	72	6	C1458155
Disease	Edema	SLC9A2 PTGS2	1.84e-03	26	72	2	C0013604
Disease	Anasarca	SLC9A2 PTGS2	1.84e-03	26	72	2	C0151603
Disease	platelet-to-lymphocyte ratio	PWWP2A TTC28 PXT1 JMJD1C RAI1	1.95e-03	363	72	5	EFO_0008446
Disease	Breast Carcinoma	IDO1 ITSN2 MKI67 PTGS2 MRPS22 EMSY	2.02e-03	538	72	6	C0678222
Disease	sodium measurement	NEGR1 SCG2 JMJD1C	2.07e-03	103	72	3	EFO_0009282
Disease	Mental Retardation, X-Linked	XK OPHN1	2.28e-03	29	72	2	C1136249

Protein segments in the cluster

Peptide	Gene	Start	Entry
PYPDELKNMVKTVQT	ERBIN	486	Q96RT1
AIKMPEKAEQYQPLT	EPB42	591	P16452
NTEKTEQQPQPYVMV	ELF1	581	P32519
MLKTFYKQENPNAPK	ADAT2	166	Q7Z6V5
NAINLYKNTPEKVMP	BUB1	876	O43683
NPMYDTNLKPTEAKA	CSMD1	3536	Q96PZ7
NSPNTYMKVNVPEES	ADD3	441	Q9UEY8
KPYNPAKMQKVDAEN	ARHGEF38	641	Q9NXL2
PPNVEKSIKKEMAQY	ACACA	911	Q13085
TIYINNMPEPKKVFC	ANGPT1	301	Q15389
VPEHSNNKMKNLSYP	ANO2	241	Q9NQ90
TFYKKVPNAEKMNEP	IQCA1	641	Q86XH1
LEKNAQESKSPFPMY	AFF4	956	Q9UHB7
ETPQPQPNSKYKTSM	RC3H2	401	Q9HBD1
MKKTAVPPSRQYAEQ	RAI1	146	Q7Z5J4
SYQKMQEEEPQKKLP	ITSN2	346	Q9NZM3
KEPIYHSPITKQQEM	OPHN1	366	O60890
QPMYQPTPTKDKDVA	SLC7A8	516	Q9UHI5
PTIISNVKPNMTCYK	ALDH6A1	401	Q02252
KQMPKYSSENSNPEQ	POTEF	481	A5A3E0
KKDPNKPLTYENMDV	IDO1	136	P14902
QVPPKIYDISNDMTV	NEGR1	136	Q7Z3B1
PYPEDLKNMVKSVQN	LRRC7	571	Q96NW7
DLYKMKHSVPQSLPQ	JMJD1C	1076	Q15652
MYNPKQKQHDPKAET	KIAA1109	111	Q2LD37
TDVKKLMSSEQYPPQ	BAIAP2L2	486	Q6UXY1
PQESMELVYNKSKPV	DYNC1I1	426	O14576
YTKETQTPVMAQPKE	DYNC1I2	156	Q13409
KKMPFSYPQQITIEK	HS3ST5	141	Q8IZT8
KKYMPAVTSTPTVNQ	PCM1	786	Q15154
TVKDTQAEMIYPPQV	PTGS2	251	P35354
EPAKMKTPVQYSQQQ	MKI67	341	P46013
ETNSAYMLSPKPQKK	GPR75	426	O95800
DNIKNDPDKEYNMPK	EXOC7	481	Q9UPT5
DNQTKKPETYLMPKD	NCF1B	131	A6NI72
DNQTKKPETYLMPKD	NCF1C	106	A8MVU1
SAKPMIKFQSPYEEQ	GOLIM4	396	O00461
MVPKNCYVSQQELKP	SMPD2	216	O60906
KQMPKYSSENSNPEQ	POTEE	481	Q6S8J3
QQPDPYANLMTRKEK	PATL2	181	C9JE40
PKEYNTPSMKEWQQI	CALHM6	246	Q5R3K3
KMPQKVISALPSYQE	DYTN	471	A2CJ06
VPEQKNYVGMQNCPK	GALNT4	506	Q8N4A0
NEPYMKIPCNDSKIT	EIF3I	136	Q13347
NNMKIPVAEYFSKPN	C4orf17	306	Q53FE4
TLPHSPQTKEYMENK	MARF1	41	Q9Y4F3
KIYVQPQTPQSQMSL	EMSY	1066	Q7Z589
PPSKIMKAVYQNISE	SLFN13	171	Q68D06
QCYVKPTKNMSPKEQ	JADE3	731	Q92613
QYPPKKVTTVIQNPM	CD22	416	P20273
VYKMLQEKQELNEPP	PDLIM1	196	O00151
KPPERKMSQNTQDGY	NXF2	106	Q9GZY0
PEQQSPELENMTKYV	PDILT	531	Q8N807
QELKPPTYKLMTQAQ	MRPS22	96	P82650
YKDKPEAMPLQSNTF	PWWP2A	211	Q96N64
EKNPQKPQYSMAVEF	PUS3	306	Q9BZE2
YKVMAAENIPENPLK	STAT1	651	P42224
KPDHVKMTYPKTQLQ	MRM3	191	Q9HC36
ENKPYALNSEKNFPM	SCG2	131	P13521
TVKEDQVFSMNPPKY	MYH4	71	Q9Y623
QVFSMNPPKYDKIED	MYH4	76	Q9Y623
KQMPKYSSENSNPEQ	POTEI	481	P0CG38
LKKEPPGYEEAMSQQ	MRTFA	721	Q969V6
VQDSMKYLDQKSPTP	CCL11	81	P51671
VKMLEKQTNPPDYLT	TOP3B	481	O95985
PEQFSKKSPQSYKME	SLC9A2	716	Q9UBY0
EDGLPEKLMQKTQQY	PSPC1	241	Q8WXF1
VPQDPKSSYLKNQML	SPATA31D1	1191	Q6ZQQ2
KPDQVFQSYKPGEVM	USP47	701	Q96K76
NKYMSNTFEPLNKPD	USP15	181	Q9Y4E8
PTYQQLQKMKLDKSP	TTC28	181	Q96AY4
MPSQNYDLPQKKQEK	ZNF227	1	Q86WZ6
YNNLMSKAEQLPKTP	ARHGAP21	1061	Q5T5U3
SLQSMKAQPKYESPE	ZSCAN12	161	O43309
QKAYMTQLVSSQPVP	PXT1	36	Q8NFP0
TDPNYHPSKKMQTKI	THEGL	316	P0DJG4
NEEPYVSITKKRQMP	XK	96	P51811
IQEPVKPTVNYKMAN	ZBBX	106	A8MT70
PKTAEEIKPEQMYQC	ZFHX3	1211	Q15911
YLKKEMNSFQQQPPP	MX2	21	P20592
KNYIPPSDMQKESQI	NECTIN3	441	Q9NQS3